Co-Investment in Private Equity: The Insider Track to Better LP Returns

    A co-investment lets you put capital directly into a single private equity deal alongside the fund, at zero carried interest and reduced or zero management fees. According to ILPA Principles 3.0, this

    ByJeff Barnes, MBA
    ·10 min read
    Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation
    Co-Investment in Private Equity: The Insider Track to Better LP Returns
    TL/DR

    A co-investment lets you put capital directly into a single private equity deal alongside the fund, at zero carried interest and reduced or zero management fees. According to ILPA Principles 3.0, this structure is one of the most powerful tools available to LPs who want to improve net returns without adding a new manager relationship. The EVLI study of 613 realized deals shows a median 2.58x MOIC for co-investments versus 2.33x for blind-pool funds. That gap is the difference between a good outcome and a great one, compounded across a portfolio.

    If you are already committed to a PE fund at the $25-50M level, you likely qualify. Most LPs at that threshold never ask. This article explains why you should, and exactly how to do it.

    What Co-Investment Actually Means

    A co-investment is direct equity participation in a specific portfolio company transaction. You are not buying into a blind pool. You are investing alongside the fund in a named company, at a known price, in a deal the GP has already underwritten.

    The GP creates a parallel vehicle or special purpose vehicle outside the commingled fund. You wire capital into that vehicle. Your money deploys into the same deal, on the same closing date, at the same purchase price as the main fund. You own a proportional economic slice of that company.

    With a blind-pool commitment, you hand a GP $50 million and trust them to deploy it across 10-15 companies over five years. With a co-investment, you review one specific opportunity, run it through your own investment committee, and write a check tied to that single transaction. You see the company before you commit. That visibility changes the risk calculus entirely.

    GPs offer co-investments for practical reasons. A deal may be too large for the fund to absorb alone. The GP may need a co-investor with specific sector expertise. The deal timeline may require staged capital. None of those reasons involve the GP trying to offload a weak deal.

    The Fee Math: What Zero Carry Saves You

    The standard private equity fund charges 2% annual management fees on committed capital plus 20% carried interest on profits. That is the 2-and-20 model. It works for the GP. It is expensive for you.

    Co-investments change that equation. Most co-investment rights come with 0% carry on co-invested capital. Management fees on co-investment capital run anywhere from zero to 200 basis points, with the industry norm closer to 50-100 basis points at larger commitment sizes.

    Run the math on a $5 million co-investment held for six years at a 2.58x gross MOIC. At zero fees, your net return mirrors the gross, turning $5 million into roughly $12.9 million. Run the same deal through 2-and-20. After annual management fee drag and 20% carry on profits, your net MOIC drops to around 2.0x-2.1x. The co-investment structure keeps an additional $2-3 million in your pocket on a single $5 million position.

    The EVLI analysis estimates 200-400 basis points of annual fee savings on co-investment capital versus blind-pool capital. Over a five-to-seven-year hold period, that compounding is material. It is the primary mechanical reason co-investments outperform on a net basis, before any deal-level performance premium is even counted.

    The Performance Data: 2.58x vs 2.33x MOIC

    The EVLI white paper analyzed 613 realized co-investment deals and 382 non-co-investment deals. The results are statistically significant. Co-investments delivered a median gross MOIC of 2.58x. Non-co-investments delivered 2.33x. That is a 10.7% advantage on a multiple basis.

    On an IRR basis, co-investments came in at a median 26.9% versus 25.3% for blind-pool deals. That 1.6 percentage point gap carries a p-value of 0.032. This is not noise from a small sample.

    The distribution data matters too. Co-investments had a loss rate of 18.1%, meaning that share of deals fell below a 1.0x MOIC. Non-co-investments lost money 25.7% of the time. That is a 7.6 percentage point difference in capital-loss frequency. On the upside, 40.6% of co-investments hit a 3.0x or better multiple. Only 35.9% of blind-pool deals reached that threshold.

    Better downside protection and better upside capture in the same dataset. That combination has a structural explanation. Co-investors pay lower fees, see the deal before committing, and concentrate capital in the GP's highest-conviction transactions. The data confirms all three effects are real.

    How to Negotiate Co-Investment Rights

    Co-investment rights are not automatic. You have to ask for them during fund formation. Once the fund closes, your leverage is largely gone.

    The primary mechanism is a side letter, a bilateral agreement between you and the GP that sits on top of the main Limited Partnership Agreement. It specifies your right to participate in a proportional share of co-investment opportunities, your minimum allocation per deal, your information rights on the pipeline, and your ability to participate in follow-on capital calls for add-on acquisitions.

    The most important clause is a Most Favored Nation provision. An MFN clause guarantees that if the GP grants any other LP more favorable co-investment terms, you receive the same benefit automatically. Without an MFN, a larger LP can negotiate better access while you receive whatever is left.

    Size matters. The threshold for co-investment eligibility typically starts at $25-50M in fund commitments. At $100-500M, you access pro-rata allocation rights. At $500M and above, you enter the tier with guaranteed allocation frameworks and designated seats on the Limited Partner Advisory Committee.

    ILPA requires GPs to disclose their co-investment allocation methodology in the fund's Private Placement Memorandum. If the PPM is vague about allocation priorities, get specifics in your side letter before you commit.

    You can learn more about negotiating LP side letters in our dedicated guide, and about your LPAC rights under ILPA Principles 3.0 in this companion piece.

    The 2-4 Week Clock

    Here is the part that trips up most LPs who are new to co-investments. The decision window is short.

    When the GP brings in co-investors, you typically have two to four weeks from initial notification to final commitment. Days zero through two: the GP sends an investment memo, a financial model, and a company overview. Days two through ten: you conduct due diligence, covering the model, management meetings, and reference checks. Days ten through fourteen: your investment committee votes. Days fourteen through twenty-one: documentation gets negotiated and executed. Days twenty-one through twenty-eight: capital call and close.

    You need an internal process ready before the opportunity arrives. That means a standing investment committee with clear decision authority, a template due diligence checklist, and pre-approved legal counsel who can turn documents quickly.

    If you cannot execute within the GP's window, you lose the allocation. Miss two or three opportunities in a row and the GP will mark you as an unreliable co-investor. Build the process before you need it.

    Who Gets Access: The Tier Structure

    Major PE firms operate explicit tier systems for co-investment access, even if they never publish them officially.

    At the top tier, commitments above $500 million unlock guaranteed allocation frameworks. CalPERS, Ontario Teachers Pension Plan, ADIA, and Nippon Life Insurance, which recently committed approximately 1.5 trillion yen to Blackstone across private credit and real estate, sit at this level. These LPs receive first call on major transactions and hold designated LPAC seats.

    The mid-tier runs from $100 million to $500 million in commitments. Large university endowments, state pension systems, and Canadian pension plans receive pro-rata co-investment access under side letter terms, with check sizes from $5 million to $20 million per deal.

    The entry tier sits at $25 million to $100 million. Smaller pension systems, multi-family offices, and fund-of-funds managers access co-investments conditionally, with check sizes from $1 million to $10 million per deal.

    Individual accredited investors below $25 million generally cannot access GP-sponsored co-investments directly. Some GPs have developed pooled vehicles or direct access programs to address this gap. Vista Equity Partners and Intermediate Capital Group have both launched programs targeting accredited investors at lower minimums. For investors working toward institutional scale, our guide on building a private equity portfolio from scratch covers the sequencing in detail.

    The Risks You Need to Understand

    Co-investments carry real risks. Anyone who tells you otherwise is selling something.

    Concentration risk is the most obvious one. A $5 million co-investment is a single-name bet. Add-on acquisitions can deepen that exposure as the GP calls additional capital over time. Set hard position limits before you start writing co-investment checks. Cap any single deal at a share of your total co-investment budget that you can afford to lose entirely.

    Illiquidity comes second. Co-investments lock up capital for five to seven years on average. The secondaries market exists, but selling a stake typically means accepting a discount to NAV. Plan to hold to exit and reserve capital for follow-on calls.

    Minority shareholder risk is real. The GP controls exit timing, strategy, and major operational decisions. Push for board observation rights and consent triggers on sale, refinancing, and dividend recapitalizations in your side letter.

    Now the adverse selection argument. The theory holds that GPs offer co-investments on deals they cannot fully finance, implying lower quality. The data says this is wrong. The EVLI study and Oxford University research by Harris, Jenkinson, and Kaplan examined this across vintages from 2012 to 2023. Co-invest deals outperformed non-co-invest deals in every time period tested. GPs offer co-investments when deals are too large for the fund to absorb alone. The size constraint is mechanical, not a quality signal.

    That said, past data does not guarantee future outcomes. Diversify across multiple deals, sectors, and fund managers.

    2026 Context: Apollo, Blackstone, and the Co-Investment Boom

    Deal sizes are growing faster than fund sizes. GPs need co-investor capital to complete their largest transactions. This structural dynamic is favorable for LPs with established co-investment rights.

    In June 2026, Apollo Global Management and Blackstone co-anchored the $35 billion AI infrastructure XPV Platform alongside Goldman Sachs, Wells Fargo, Citi, and several other institutional partners. No single fund could finance that volume alone. The co-investment structure was the only mechanism capable of deploying that capital into a single platform.

    Nippon Life Insurance committed approximately 1.5 trillion yen to Blackstone in a five-year strategic partnership covering private credit and real estate, a direct illustration of how mega-institutions use fund scale to unlock preferred deal access.

    Apollo's October 2025 partnership with 8VC created a dedicated co-investment vehicle targeting advanced manufacturing, aerospace, energy, and life sciences. The pattern is consistent. GPs with the largest deal pipelines are building co-investment infrastructure because they need it. That creates leverage for LPs who are positioned correctly.

    Jeff's Take

    Co-investment is the most underused return-improvement tool available to LPs already in the $25-50M commitment range.

    Zero carry on co-invested capital is not a minor concession from the GP. It is a structural shift in how economics are split on those transactions. Combine that with the 2.58x versus 2.33x MOIC premium from the EVLI data and the 18.1% versus 25.7% loss rate differential, and you have a strategy with validated, statistically significant advantages across hundreds of realized deals.

    The path is straightforward. Commit at the $25-50M threshold. Negotiate co-investment capacity rights in your side letter during fund formation. Include an MFN clause. Build an internal process that can make decisions in two weeks. Diversify across at least five to ten co-investments to manage concentration risk. Reserve capital for follow-on calls.

    It is the playbook that institutional LPs have been running at every major PE firm for years. For LPs who want to structure these rights from the beginning of a GP relationship, our fund commitment negotiation guide covers the full process from first meeting through side letter execution.

    The data is clear. The mechanism is available. The work is in the preparation.

    Sources


    Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    J

    About the Author

    Jeff Barnes, MBA